Chengdu Rongsheng Pharmaceutical

Chengdu Rongsheng Pharmaceutical, a plasma-processing firm based in China, has been crafting quality plasma-derived therapies since 1997. Specializing in the production of plasma derivatives such as albumin, intravenous immunoglobulin, as well as hepatitis B and tetanus immunoglobulins, the company has established itself as a key player in the biotechnology industry. Initially part of the Chengdu Institute Of Biological Products, it transitioned to become a subsidiary of Beijing Tiantan Biological Products Co., Ltd. after a transaction on June 24, 2008. With a slogan that highlights its commitment to a healthier tomorrow, Chengdu Rongsheng Pharmaceutical is poised for further growth and innovation in the biopharmaceutical sector.